KOLOA, Hawaii — Having a standard method of communication in place for staff helps prevent wrong intravitreous injections, according to a speaker here. During a Retina 2023 presentation, Robin A. Vora ...
The pharmaceutical company Gilead has announced that its new pre-exposure prophylactic (PrEP) injectable medication has passed a Phase III clinical trial demonstrating its safety and effectiveness ...
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
The FDA has approved lenacapvir, a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications. The drug, which will be sold under the brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback